Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2023-04-09 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2023 first extraordinary shareholders' meeting of Shanxi Dayu Bioengineering Co., Ltd. It details the meeting's convening, attendance, agenda items, voting results, and changes in board members and senior management. The content focuses on the official announcement of voting results and decisions made at the shareholders' meeting, including board member resignations and appointments. The document length is 4143 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial data or comprehensive report content. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-04-09 Chinese
2023年第一次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening and proceedings of the 2023 first extraordinary general meeting (临时股东大会) of Shanxi Dayu Biological Engineering Co., Ltd. It details the legality of the meeting's convening, the qualifications of attendees, the voting procedures, and the results of the shareholder votes on various proposals. The document does not contain financial statements or management discussion of financial results, nor is it a report publication announcement. It is a legal opinion related to the shareholder meeting and the voting results. This fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the shareholder meeting.
2023-04-09 Chinese
关于召开 2023 年第一次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2023 first extraordinary general meeting of shareholders (临时股东大会) for Shanxi Dayu Biological Engineering Co., Ltd. It details the meeting date, voting methods, agenda items including board nominations and financial proposals, and procedural information for shareholders. It does not contain actual financial statements or results, nor is it a transcript or report of the meeting outcomes. It is a formal announcement of a shareholders meeting, not the meeting materials or results themselves. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-03-22 Chinese
关于2023年拟向银行及其他金融机构申请综合授信额度贷款公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shanxi Dayu Bioengineering Co., Ltd. regarding its plan to apply for a comprehensive credit loan from banks and other financial institutions in 2023. It details the loan amount, types of credit involved, authorization for signing loan documents, and board meeting approval. There is no financial statement or detailed financial analysis present. The document is a financing update about the company's capital structure and funding plans. It is not a full financial report, earnings release, or regulatory filing. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it is not merely announcing a report publication, so it is not RPA or RNS.
2023-03-22 Chinese
独立董事关于第三届董事会第七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's third board meeting, including nominations for board candidates, appointment of a general manager, anticipated related party transactions, and entrusted financial management. It contains no financial statements or detailed financial data but rather opinions and approvals related to board and management decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or appointments in the company's board or senior management.
2023-03-22 Chinese
委托理财的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanxi Dayu Bioengineering Co., Ltd. regarding the company's plan to use idle funds for entrusted financial management (委托理财). It details the purpose, amount, methods, duration, risk analysis, and approval procedures related to this financial activity. The document is relatively short (1359 characters) and focuses on informing shareholders and the public about a financing-related update rather than presenting financial statements or results. There is no indication of it being a full financial report, earnings release, or audit report. The content fits best under Capital/Financing Update (CAP) as it concerns the company's financing activities and capital management strategies.
2023-03-22 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.